AGREEMENT AND PLAN OF MERGER by and among Crown Laboratories, Inc. Reba Merger Sub, Inc. and Revance Therapeutics, Inc. August 11, 2024Merger Agreement • August 12th, 2024 • Revance Therapeutics, Inc. • Pharmaceutical preparations • Delaware
THIS AGREEMENT AND PLAN OF MERGER (this “Agreement”) is made and entered into as of August 11, 2024, by and among Crown Laboratories, Inc., a Delaware corporation (“Parent”), Reba Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Parent (“Merger Sub,” and together with Parent, the “Buyer Parties”), and Revance Therapeutics, Inc., a Delaware corporation (the “Company”). Each of the Company, Parent and Merger Sub is sometimes referred to as a “Party.” Certain capitalized terms that are used in this Agreement have the respective meanings given to them in Article I.
